PetMed Express, Inc. (PETS)
USD 5.28
(-5.38%)
USD 5.28
(-5.38%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -53.84 Million USD | 48.27% |
| 2023 | -104.08 Million USD | 6.3% |
| 2022 | -111.08 Million USD | 6.43% |
| 2021 | -118.71 Million USD | -14.41% |
| 2020 | -103.76 Million USD | -3.22% |
| 2019 | -100.52 Million USD | -28.99% |
| 2018 | -77.93 Million USD | -32.7% |
| 2017 | -58.73 Million USD | -56.03% |
| 2016 | -37.63 Million USD | -5.69% |
| 2015 | -35.61 Million USD | -94.55% |
| 2014 | -18.3 Million USD | -0.83% |
| 2013 | -18.15 Million USD | 61.21% |
| 2012 | -46.8 Million USD | 5.76% |
| 2011 | -49.66 Million USD | 6.55% |
| 2010 | -53.14 Million USD | -76.4% |
| 2009 | -30.12 Million USD | -48.64% |
| 2008 | -20.26 Million USD | -6304.34% |
| 2007 | -316.47 Thousand USD | 98.64% |
| 2006 | -23.21 Million USD | -83.08% |
| 2005 | -12.68 Million USD | -294.99% |
| 2004 | -3.21 Million USD | -278.91% |
| 2003 | -847.28 Thousand USD | -116.84% |
| 2002 | -390.74 Thousand USD | -125.27% |
| 2001 | 1.54 Million USD | -38.69% |
| 2000 | 2.52 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 FY | -53.84 Million USD | 48.27% |
| 2024 Q1 | -59.46 Million USD | 42.87% |
| 2024 Q2 | -51.63 Million USD | 13.17% |
| 2024 Q3 | -47.79 Million USD | 7.43% |
| 2024 Q4 | -53.84 Million USD | -12.64% |
| 2023 Q1 | -105.41 Million USD | 5.1% |
| 2023 FY | -104.08 Million USD | 6.3% |
| 2023 Q2 | -96.54 Million USD | 8.41% |
| 2023 Q3 | -102.42 Million USD | -6.09% |
| 2023 Q4 | -104.08 Million USD | -1.62% |
| 2022 FY | -111.08 Million USD | 6.43% |
| 2022 Q3 | -108.91 Million USD | -2.2% |
| 2022 Q4 | -111.08 Million USD | -1.99% |
| 2022 Q1 | -111.78 Million USD | 5.84% |
| 2022 Q2 | -106.56 Million USD | 4.67% |
| 2021 Q4 | -118.71 Million USD | -11.47% |
| 2021 Q1 | -86.82 Million USD | 16.33% |
| 2021 FY | -118.71 Million USD | -14.41% |
| 2021 Q3 | -106.5 Million USD | -0.15% |
| 2021 Q2 | -106.34 Million USD | -22.49% |
| 2020 Q1 | -83.39 Million USD | 17.04% |
| 2020 Q3 | -92.37 Million USD | 2.66% |
| 2020 Q4 | -103.76 Million USD | -12.33% |
| 2020 FY | -103.76 Million USD | -3.22% |
| 2020 Q2 | -94.89 Million USD | -13.79% |
| 2019 Q1 | -94.56 Million USD | -21.33% |
| 2019 Q4 | -100.52 Million USD | -7.9% |
| 2019 Q3 | -93.16 Million USD | -6.93% |
| 2019 FY | -100.52 Million USD | -28.99% |
| 2019 Q2 | -87.13 Million USD | 7.86% |
| 2018 Q1 | -68.52 Million USD | -16.68% |
| 2018 Q2 | -68.44 Million USD | 0.12% |
| 2018 Q3 | -80.99 Million USD | -18.34% |
| 2018 Q4 | -77.93 Million USD | 3.78% |
| 2018 FY | -77.93 Million USD | -32.7% |
| 2017 Q1 | -44.3 Million USD | -17.72% |
| 2017 FY | -58.73 Million USD | -56.03% |
| 2017 Q4 | -58.73 Million USD | -22.6% |
| 2017 Q3 | -47.9 Million USD | 7.69% |
| 2017 Q2 | -51.89 Million USD | -17.13% |
| 2016 Q3 | -47.12 Million USD | -11.73% |
| 2016 Q4 | -37.63 Million USD | 20.14% |
| 2016 FY | -37.63 Million USD | -5.69% |
| 2016 Q2 | -42.18 Million USD | 1.18% |
| 2016 Q1 | -42.68 Million USD | -19.86% |
| 2015 Q3 | -37.06 Million USD | -7.2% |
| 2015 Q1 | -29.14 Million USD | -59.2% |
| 2015 Q4 | -35.61 Million USD | 3.93% |
| 2015 FY | -35.61 Million USD | -94.55% |
| 2015 Q2 | -34.57 Million USD | -18.66% |
| 2014 Q2 | -35.91 Million USD | -2.61% |
| 2014 FY | -18.3 Million USD | -0.83% |
| 2014 Q4 | -18.3 Million USD | 29.43% |
| 2014 Q3 | -25.93 Million USD | 27.78% |
| 2014 Q1 | -34.99 Million USD | -92.77% |
| 2013 Q3 | -30.01 Million USD | 36.19% |
| 2013 Q4 | -18.15 Million USD | 39.52% |
| 2013 Q2 | -47.04 Million USD | 17.98% |
| 2013 Q1 | -57.35 Million USD | -22.54% |
| 2013 FY | -18.15 Million USD | 61.21% |
| 2012 Q1 | -49.41 Million USD | 0.5% |
| 2012 Q2 | -47.13 Million USD | 4.6% |
| 2012 FY | -46.8 Million USD | 5.76% |
| 2012 Q4 | -46.8 Million USD | -11.52% |
| 2012 Q3 | -41.96 Million USD | 10.97% |
| 2011 FY | -49.66 Million USD | 6.55% |
| 2011 Q4 | -49.66 Million USD | 18.93% |
| 2011 Q3 | -61.25 Million USD | -1.24% |
| 2011 Q2 | -60.5 Million USD | 9.54% |
| 2011 Q1 | -66.88 Million USD | -25.86% |
| 2010 Q4 | -53.14 Million USD | 6.11% |
| 2010 Q1 | -59.5 Million USD | -97.51% |
| 2010 Q2 | -56.18 Million USD | 5.57% |
| 2010 Q3 | -56.6 Million USD | -0.74% |
| 2010 FY | -53.14 Million USD | -76.4% |
| 2009 Q4 | -30.12 Million USD | -10.8% |
| 2009 Q3 | -27.19 Million USD | 6.13% |
| 2009 Q2 | -28.96 Million USD | 24.94% |
| 2009 Q1 | -38.59 Million USD | -90.41% |
| 2009 FY | -30.12 Million USD | -48.64% |
| 2008 Q4 | -20.26 Million USD | -846.97% |
| 2008 Q1 | -2 Million USD | -532.08% |
| 2008 Q2 | -7.39 Million USD | -269.45% |
| 2008 Q3 | -2.14 Million USD | 71.04% |
| 2008 FY | -20.26 Million USD | -6304.34% |
| 2007 Q2 | -37.66 Million USD | -13.71% |
| 2007 FY | -316.47 Thousand USD | 98.64% |
| 2007 Q3 | -38.16 Million USD | -1.34% |
| 2007 Q4 | -316.47 Thousand USD | 99.17% |
| 2007 Q1 | -33.12 Million USD | -42.67% |
| 2006 Q2 | -25.61 Million USD | -23.71% |
| 2006 Q4 | -23.21 Million USD | 12.85% |
| 2006 Q3 | -26.64 Million USD | -4.0% |
| 2006 Q1 | -20.7 Million USD | -63.3% |
| 2006 FY | -23.21 Million USD | -83.08% |
| 2005 Q1 | -5.11 Million USD | -59.21% |
| 2005 FY | -12.68 Million USD | -294.99% |
| 2005 Q4 | -12.68 Million USD | -63.11% |
| 2005 Q2 | -10.78 Million USD | -111.09% |
| 2005 Q3 | -7.77 Million USD | 27.94% |
| 2004 FY | -3.21 Million USD | -278.91% |
| 2004 Q1 | -1.37 Million USD | -62.02% |
| 2004 Q3 | 1.38 Million USD | 130.15% |
| 2004 Q2 | -4.59 Million USD | -234.46% |
| 2004 Q4 | -3.21 Million USD | -331.93% |
| 2003 Q4 | -847.28 Thousand USD | -182.85% |
| 2003 FY | -847.28 Thousand USD | -116.84% |
| 2003 Q3 | 1.02 Million USD | 212.05% |
| 2003 Q2 | -912.69 Thousand USD | -1008.81% |
| 2003 Q1 | 100.42 Thousand USD | 125.7% |
| 2002 Q1 | 122.01 Thousand USD | -92.11% |
| 2002 Q2 | 191.39 Thousand USD | 56.86% |
| 2002 Q3 | -171.22 Thousand USD | -189.46% |
| 2002 Q4 | -390.74 Thousand USD | -128.2% |
| 2002 FY | -390.74 Thousand USD | -125.27% |
| 2001 Q2 | 1.85 Million USD | -23.33% |
| 2001 Q1 | 2.41 Million USD | -3.47% |
| 2001 Q3 | 1.42 Million USD | -22.89% |
| 2001 Q4 | 1.54 Million USD | 8.4% |
| 2001 FY | 1.54 Million USD | -38.69% |
| 2000 FY | 2.52 Million USD | 0.0% |
| 2000 Q4 | 2.5 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | -655.73 Thousand USD | -8111.001% |
| BIMI International Medical Inc. | 3.11 Million USD | 1826.421% |
| China Jo-Jo Drugstores, Inc. | 10.34 Million USD | 620.424% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 116.41 Million USD | 146.249% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 109.08 Million USD | 149.357% |
| Leafly Holdings, Inc. | 13.79 Million USD | 490.386% |
| Leafly Holdings, Inc. | 13.79 Million USD | 490.386% |
| LifeMD, Inc. | -14.21 Million USD | -278.786% |
| LifeMD, Inc. | -14.21 Million USD | -278.786% |
| TRxADE HEALTH, Inc. | 6.95 Million USD | 874.482% |
| Walgreens Boots Alliance, Inc. | 8.23 Billion USD | 100.654% |